CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-037337
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
  
Protein Name
 DNA topoisomerase 2 
Protein Synonyms/Alias
  
Gene Name
 TOP2B 
Gene Synonyms/Alias
  
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
3*****MAKSGGCGAGubiquitination[1]
29WVNNAAKKEESETANubiquitination[1]
37EESETANKNDSSKKLubiquitination[2]
112LVNAADNKQRDKNMTubiquitination[1, 2, 3, 4, 5]
116ADNKQRDKNMTCIKVubiquitination[1]
139ISIWNNGKGIPVVEHubiquitination[1, 2]
147GIPVVEHKVEKVYVPubiquitination[1, 2, 3, 6]
150VVEHKVEKVYVPALIubiquitination[1, 6]
172SNYDDDEKKVTGGRNubiquitination[1, 5]
173NYDDDEKKVTGGRNGubiquitination[1]
184GRNGYGAKLCNIFSTubiquitination[1, 6]
200FTVETACKEYKHSFKubiquitination[1]
216TWMNNMMKTSEAKIKubiquitination[1]
223KTSEAKIKHFDGEDYubiquitination[1]
249FKMEKLDKDIVALMTubiquitination[5, 7]
270AGSCRGVKVMFNGKKacetylation[6, 8]
277KVMFNGKKLPVNGFRubiquitination[1]
292SYVDLYVKDKLDETGubiquitination[1]
294VDLYVKDKLDETGVAubiquitination[1, 2]
303DETGVALKVIHELANubiquitination[1, 2, 3]
337VNSIATTKGGRHVDYubiquitination[1, 6, 7]
352VVDQVVGKLIEVVKKubiquitination[1]
360LIEVVKKKNKAGVSVubiquitination[1]
362EVVKKKNKAGVSVKPubiquitination[1, 2]
368NKAGVSVKPFQVKNHacetylation[6]
368NKAGVSVKPFQVKNHubiquitination[1, 6]
402ENMTLQPKSFGSKCQubiquitination[1, 7]
407QPKSFGSKCQLSEKFubiquitination[1, 3, 4, 6]
413SKCQLSEKFFKAASNubiquitination[1]
434ILNWVKFKAQTQLNKubiquitination[1]
447NKKCSSVKYSKIKGIacetylation[6]
466DANDAGGKHSLECTLubiquitination[1]
482LTEGDSAKSLAVSGLubiquitination[1, 3]
505GVFPLRGKILNVREAubiquitination[1, 6, 7]
515NVREASHKQIMENAEubiquitination[1, 2, 3, 4, 5, 6, 7]
535KIVGLQYKKSYDDAEubiquitination[1, 4]
536IVGLQYKKSYDDAESubiquitination[1, 2, 6, 7]
545YDDAESLKTLRYGKIubiquitination[1, 2, 3, 5, 6, 7]
551LKTLRYGKIMIMTDQubiquitination[1, 2, 5, 7]
595EFITPIVKASKNKQEubiquitination[1, 2, 5]
600IVKASKNKQELSFYSubiquitination[1, 2, 4, 5, 6]
615IPEFDEWKKHIENQKubiquitination[1, 2]
622KKHIENQKAWKIKYYubiquitination[1, 2, 3]
630AWKIKYYKGLGTSTAubiquitination[1, 2, 6]
638GLGTSTAKEAKEYFAubiquitination[1, 2, 6]
641TSTAKEAKEYFADMEubiquitination[1, 2, 5, 6]
671AITLAFSKKKIDDRKubiquitination[1, 2, 3, 4, 5]
672ITLAFSKKKIDDRKEubiquitination[1, 6]
678KKKIDDRKEWLTNFMubiquitination[1, 2, 6, 7]
707FLYGTATKHLTYNDFubiquitination[1, 2, 3, 5]
739PSLVDGFKPGQRKVLubiquitination[1, 6, 7]
744GFKPGQRKVLFTCFKubiquitination[1]
751KVLFTCFKRNDKREVubiquitination[1]
912LPNYKNFKGTIQELGubiquitination[1]
965PMLNGTDKTPALISDubiquitination[2]
974PALISDYKEYHTDTTubiquitination[2]
983YHTDTTVKFVVKMTEubiquitination[7]
987TTVKFVVKMTEEKLAacetylation[8]
987TTVKFVVKMTEEKLAubiquitination[1]
1003AEAAGLHKVFKLQTTubiquitination[7]
1063MLGAESTKLNNQARFubiquitination[2]
1074QARFILEKIQGKITIubiquitination[1, 6]
1078ILEKIQGKITIENRSubiquitination[1]
1086ITIENRSKKDLIQMLubiquitination[1]
1104GYESDPVKAWKEAQEubiquitination[1]
Reference
 [1] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.
 Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA.
 Mol Cell Proteomics. 2013 Mar;12(3):825-31. [PMID: 23266961]
 [2] Systematic and quantitative assessment of the ubiquitin-modified proteome.
 Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP.
 Mol Cell. 2011 Oct 21;44(2):325-40. [PMID: 21906983]
 [3] Global identification of modular cullin-RING ligase substrates.
 Emanuele MJ, Elia AE, Xu Q, Thoma CR, Izhar L, Leng Y, Guo A, Chen YN, Rush J, Hsu PW, Yen HC, Elledge SJ.
 Cell. 2011 Oct 14;147(2):459-74. [PMID: 21963094]
 [4] Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.
 Udeshi ND, Mani DR, Eisenhaure T, Mertins P, Jaffe JD, Clauser KR, Hacohen N, Carr SA.
 Mol Cell Proteomics. 2012 May;11(5):148-59. [PMID: 22505724]
 [5] Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization.
 Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, Gygi SP, Harper JW.
 Nature. 2013 Apr 18;496(7445):372-6. [PMID: 23503661]
 [6] Integrated proteomic analysis of post-translational modifications by serial enrichment.
 Mertins P, Qiao JW, Patel J, Udeshi ND, Clauser KR, Mani DR, Burgess MW, Gillette MA, Jaffe JD, Carr SA.
 Nat Methods. 2013 Jul;10(7):634-7. [PMID: 23749302]
 [7] A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.
 Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C.
 Mol Cell Proteomics. 2011 Oct;10(10):M111.013284. [PMID: 21890473]
 [8] Proteomic investigations of lysine acetylation identify diverse substrates of mitochondrial deacetylase sirt3.
 Sol EM, Wagner SA, Weinert BT, Kumar A, Kim HS, Deng CX, Choudhary C.
 PLoS One. 2012;7(12):e50545. [PMID: 23236377
Functional Description
 Control of topological states of DNA by transient breakage and subsequent rejoining of DNA strands. Topoisomerase II makes double-strand breaks (By similarity). 
Sequence Annotation
  
Keyword
 ATP-binding; Complete proteome; DNA-binding; Isomerase; Nucleotide-binding; Reference proteome; Topoisomerase. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 1150 AA 
Protein Sequence
MAKSGGCGAG AGVGGGNGAL TWVNNAAKKE ESETANKNDS SKKLSVERVY QKKTQLEHIL 60
LRPDTYIGSV EPLTQFMWVY DEDVGMNCRE VTFVPGLYKI FDEILVNAAD NKQRDKNMTC 120
IKVSIDPESN IISIWNNGKG IPVVEHKVEK VYVPALIFGQ LLTSSNYDDD EKKVTGGRNG 180
YGAKLCNIFS TKFTVETACK EYKHSFKQTW MNNMMKTSEA KIKHFDGEDY TCITFQPDLS 240
KFKMEKLDKD IVALMTRRAY DLAGSCRGVK VMFNGKKLPV NGFRSYVDLY VKDKLDETGV 300
ALKVIHELAN ERWDVCLTLS EKGFQQISFV NSIATTKGGR HVDYVVDQVV GKLIEVVKKK 360
NKAGVSVKPF QVKNHIWVFI NCLIENPTFD SQTKENMTLQ PKSFGSKCQL SEKFFKAASN 420
CGIVESILNW VKFKAQTQLN KKCSSVKYSK IKGIPKLDDA NDAGGKHSLE CTLILTEGDS 480
AKSLAVSGLG VIGRDRYGVF PLRGKILNVR EASHKQIMEN AEINNIIKIV GLQYKKSYDD 540
AESLKTLRYG KIMIMTDQDQ DGSHIKGLLI NFIHHNWPSL LKHGFLEEFI TPIVKASKNK 600
QELSFYSIPE FDEWKKHIEN QKAWKIKYYK GLGTSTAKEA KEYFADMERH RILFRYAGPE 660
DDAAITLAFS KKKIDDRKEW LTNFMEDRRQ RRLHGLPEQF LYGTATKHLT YNDFINKELI 720
LFSNSDNERS IPSLVDGFKP GQRKVLFTCF KRNDKREVKV AQLAGSVAEM SAYHHGEQAL 780
MMTIVNLAQN FVGSNNINLL QPIGQFGTRL HGGKDAASPR YIFTMLSTLA RLLFPAVDDN 840
LLKFLYDDNQ RVEPEWYIPI IPMVLINGAE GIGTGWACKL PNYDAREIVN NVRRMLDGLD 900
PHPMLPNYKN FKGTIQELGQ NQYAVSGEIF VVDRNTVEIT ELPVRTWTQV YKEQVLEPML 960
NGTDKTPALI SDYKEYHTDT TVKFVVKMTE EKLAQAEAAG LHKVFKLQTT LTCNSMVLFD 1020
HMGCLKKYET VQDILKEFFD LRLSYYGLRK EWLVGMLGAE STKLNNQARF ILEKIQGKIT 1080
IENRSKKDLI QMLVQRGYES DPVKAWKEAQ EKAAEEDETQ NQHDDSSSDS GTPSGPDFNY 1140
ILNMSLWSLT 1150 
Gene Ontology
 GO:0005694; C:chromosome; IEA:InterPro.
 GO:0005634; C:nucleus; IEA:Compara.
 GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
 GO:0003918; F:DNA topoisomerase type II (ATP-hydrolyzing) activity; IEA:EC.
 GO:0007409; P:axonogenesis; IEA:Compara.
 GO:0006265; P:DNA topological change; IEA:InterPro.
 GO:0030900; P:forebrain development; IEA:Compara.
 GO:0001764; P:neuron migration; IEA:Compara. 
Interpro
 IPR024946; Arg_repress_C-like.
 IPR003594; HATPase_ATP-bd.
 IPR020568; Ribosomal_S5_D2-typ_fold.
 IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
 IPR001241; Topo_IIA.
 IPR002205; Topo_IIA_A/C.
 IPR013758; Topo_IIA_A/C_ab.
 IPR013757; Topo_IIA_A_a.
 IPR013506; Topo_IIA_bsu_dom2.
 IPR013759; Topo_IIA_cen_dom.
 IPR013760; Topo_IIA_like_dom.
 IPR018522; TopoIIA_CS.
 IPR006171; Toprim_domain. 
Pfam
 PF00204; DNA_gyraseB
 PF00521; DNA_topoisoIV
 PF02518; HATPase_c
 PF01751; Toprim 
SMART
 SM00387; HATPase_c
 SM00433; TOP2c
 SM00434; TOP4c 
PROSITE
 PS00177; TOPOISOMERASE_II 
PRINTS
 PR00418; TPI2FAMILY.